<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02859636</url>
  </required_header>
  <id_info>
    <org_study_id>P/2012/140</org_study_id>
    <nct_id>NCT02859636</nct_id>
  </id_info>
  <brief_title>Pronostic Value of Endothelial Dysfunction in Heart Failure</brief_title>
  <acronym>Pro-ICARD</acronym>
  <official_title>Pronostic Value of Endothelial Dysfunction in Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Besancon</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective is to evaluate the pronostic value of endothelial dysfonction in acute
      heart failure on a combined criteria associating cardiovascular mortality, nex
      hospitalisation for decompensated heart failure, cardiac graft or ventricular assistance 2
      month and 1 year before acute heart failure.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Not enough inclusions
  </why_stopped>
  <start_date>October 2012</start_date>
  <completion_date type="Actual">March 2016</completion_date>
  <primary_completion_date type="Actual">March 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>MR Proadrenomedulline</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>catecholamins</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>late endothelial progenitors</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Peripheral tissular perfusion</measure>
    <time_frame>6 months</time_frame>
    <description>Near infra-red spectroscopy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>mortality</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>hospitalisation</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <enrollment type="Actual">7</enrollment>
  <condition>Heart Decompensation</condition>
  <condition>Cardiac Failure</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum samples, endothelial progenitors
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with more than 18 years and less than 81 years, hospitalized for acute heart
        failure with left ventricular impairment (LVEF &lt; 45%)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients hospitalized for acute heart fialure with Left Ventricular Ejection Fraction
             (LVEF) &lt; 45 % on echocardiography

        Exclusion Criteria:

          -  Informed consent form not signed

          -  Cardiogenic, septic or hemorragic shock

          -  Acute coronary syndrom with elevated troponin

          -  valvular surgery or aorto-coronary graft during next 3 months

          -  Cancer

          -  Pregnancy

          -  life expectancy over than 1 year

          -  chronic renal impairment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>81 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 2, 2016</study_first_submitted>
  <study_first_submitted_qc>August 4, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 9, 2016</study_first_posted>
  <last_update_submitted>August 4, 2016</last_update_submitted>
  <last_update_submitted_qc>August 4, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 9, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

